Make your selection

List of Withaferin A and group Metabolic Disorder intersectionsRows: 8■ Human ■ Animal ■ Risk ■ Review

SubstanceConditionSeqSrc
PMID
Dtl
Title
Withaferin A Glucose Metabolism Disorder
1
PM
30417321📋Withaferin A Protects Against High-Fat Diet-Induced Obesity Via Attenuation of Oxidative Stress, Inflammation, and Insulin Resistance
Withaferin A Hypercholesterolemia
1
PM
35608923📋In-silico validation of novel therapeutic activities of withaferin a using molecular docking and dynamics studies
Withaferin A Hyperlipidemia
1
PM
35734936📋Modulatory action of withaferin-A on oxidative damage through regulation of inflammatory mediators and apoptosis via PI3K/AKT signaling pathway in high cholesterol-induced atherosclerosis in experimental rats
Withaferin A Metabolic Disorders
1
PM
30417321📋Withaferin A Protects Against High-Fat Diet-Induced Obesity Via Attenuation of Oxidative Stress, Inflammation, and Insulin Resistance
Withaferin A Obesity
1
PM
33444942📋Withaferin A exerts an anti-obesity effect by increasing energy expenditure through thermogenic gene expression in high-fat diet-fed obese mice
Withaferin A Obesity
2
PM
32046183📋Withania somnifera Extract Enhances Energy Expenditure via Improving Mitochondrial Function in Adipose Tissue and Skeletal Muscle
Withaferin A Obesity
4
PM
31226166📋Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice
Withaferin A Obesity
3
PM
30417321📋Withaferin A Protects Against High-Fat Diet-Induced Obesity Via Attenuation of Oxidative Stress, Inflammation, and Insulin Resistance